KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Receivables - Net (2018 - 2025)

Twist Bioscience (TWST) has disclosed Receivables - Net for 6 consecutive years, with $42.6 million as the latest value for Q2 2023.

  • On a quarterly basis, Receivables - Net rose 3.36% to $42.6 million in Q2 2023 year-over-year; TTM through Jun 2023 was $42.6 million, a 3.36% increase, with the full-year FY2022 number at $40.3 million, changed N/A from a year prior.
  • Receivables - Net was $42.6 million for Q2 2023 at Twist Bioscience, down from $43.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $44.4 million in Q4 2022 to a low of $8.0 million in Q1 2019.
  • A 5-year average of $26.2 million and a median of $27.3 million in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: skyrocketed 137.94% in 2020, then rose 3.36% in 2023.
  • Twist Bioscience's Receivables - Net stood at $12.5 million in 2019, then surged by 104.34% to $25.5 million in 2020, then rose by 7.39% to $27.4 million in 2021, then soared by 62.33% to $44.4 million in 2022, then dropped by 4.18% to $42.6 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Receivables - Net are $42.6 million (Q2 2023), $43.2 million (Q1 2023), and $44.4 million (Q4 2022).